Vitae Pharmaceuticals: Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials Of BACE Inhibitor BI1181181/VTP-37948 In Alzheimer's Disease
October 23, 2014 at 16:14 PM EDT
Co announced positive top-line results from clinical trials in treatment and prevention of Alzheimer's disease as part of the ...